Advances in Clinical Chemistry. (notice n° 28113)
| 000 -LEADER | |
|---|---|
| fixed length control field | 05649cam a2200649Mi 4500 |
| 001 - CONTROL NUMBER | |
| control field | ocn823719558 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20211202094852.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION | |
| fixed length control field | m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr |n||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 130109s2013 vtu o 000 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | EBLCP |
| Language of cataloging | eng |
| Transcribing agency | EBLCP |
| Modifying agency | OCLCQ |
| -- | N$T |
| -- | YDXCP |
| -- | OCLCQ |
| -- | OCLCO |
| -- | OPELS |
| -- | IDEBK |
| -- | OCLCF |
| Description conventions | rda |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780124058521 (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0124058523 (electronic bk.) |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)823719558 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RB1 .A2 2013 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED |
| Subject category code subdivision | 014000 |
| Source | bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | SCI |
| Subject category code subdivision | 013020 |
| Source | bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.0756 |
| 049 ## - LOCAL HOLDINGS (OCLC) | |
| Holding library | TEFA |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Makowski, Gregory. |
| 9 (RLIN) | 4654 |
| 245 10 - TITLE STATEMENT | |
| Title | Advances in Clinical Chemistry. |
| 264 #1 - | |
| -- | Burlington : |
| -- | Elsevier Science, |
| -- | 2013. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (285 pages) |
| 336 ## - CONTENT TYPE | |
| Content Type Term | text |
| Content Type Code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media Type Term | computer |
| Media Type Code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier Type Term | online resource |
| Carrier Type Code | cr |
| Source | rdacarrier |
| 347 ## - | |
| -- | data file |
| -- | rda |
| 490 1# - SERIES STATEMENT | |
| Series statement | Advances in Clinical Chemistry |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Front Cover; Advances in Clinical Chemistry; Copyright; Contents; Contributors; Preface; Chapter One: Human Epididymis Protein 4 in Cancer Diagnostics: A Promising and Reliable Tumor Marker; 1. Introduction; 2. General Characteristics; 3. Analytical Methods; 3.1. Enzyme-linked immunosorbent assay; 3.2. Chemiluminescent microparticle immunoassay; 3.3. Bead-based array system; 4. Cancer Diagnostics; 4.1. Ovarian cancer; 4.2. Endometrial cancer; 4.3. Breast cancer; 4.4. Transitional cell carcinoma; 4.5. Lung cancer; 4.6. Pancreatic cancer; 4.7. Other tumors; 5. Discussion; References. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Chapter Two: Pathophysiological Roles and Clinical Importance of Biomarkers in Acute Coronary Syndrome1. Introduction; 2. Pathogenesis Underlying Myocardial Ischemia/Infarction; 3. Ideal Cardiac Biomarkers; 4. History of Cardiac Biomarkers; 5. Myocardial Dysfunction; 5.1. B-type natriuretic peptide; 6. Myocardial Necrosis; 6.1. Cardiac troponins; 6.2. Creatine kinase MB; 6.3. Myoglobin; 6.4. Heart-type fatty acid-binding protein; 7. Myocardial Ischemia; 7.1. Choline; 7.2. Ischemia-modified albumin; 8. Biomarkers of Inflammation; 8.1. Acute-phase response; 8.1.1. C-reactive protein. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 8.2. Plaque rupture8.2.1. Pregnancy-associated plasma protein A; 8.2.2. Soluble CD40 ligand; 8.3. Plaque destabilization; 8.3.1. Matrix metalloproteinase 9; 8.3.2. Myeloperoxidase; 8.3.3. Neopterin; 9. Perspectives and Future Strategies; 10. Conclusion; References; Chapter Three: Paraoxonases: Ancient Substrate Hunters and Their Evolving Role in Ischemic Heart Disease; 1. Historical Overview: From Toxicology to Cardiovascular Disease; 2. The PON Enzyme Family; 2.1. Serum paraoxonase -- PON1: The best-known paraoxonase; 2.2. PON2 and PON3. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 3. PON as Multitasking Enzymes: Pathways Related to Atherosclerosis3.1. Antioxidant function and protection; 3.2. PON1 and macrophage interaction in atherosclerosis; 3.3. Homocysteine-thiolactone: Vascular toxicity and inflammation; 3.4. PON and innate immunity: A new link to cardiovascular disease; 3.5. PON1: A possible determinant of clopidogrel efficacy; 3.6. PON2: Beyond intracellular antioxidant function; 4. PON and Ischemic Heart Disease: Animal Studies; 5. PON and Ischemic Heart Disease: Epidemiologic and Clinical Studies; 5.1. PON1 activities; 5.2. PON1 genotypes; 5.3. PON2 genotypes. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 5.4. PON genotypes in genome-wide association studies6. PON1 as a Potential Therapeutic Tool; 7. Concluding Remarks; References; Chapter Four: Mucosal Healing in Ulcerative Colitis: Pathophysiology and Pharmacology; 1. Introduction; 2. Molecular Pathways of Intestinal Mucosal Wounding in Ulcerative Colitis; 2.1. Intrinsic molecular wound-healing pathways in epithelial cells; 2.2. Luminal factors; 2.3. Lamina propria: Epithelial cell interactions in wound healing; 3. Epithelial Healing in Ulcerative Colitis Has an Impact on Disease Course; 4. The Pharmacodynamics of Wound Healing. |
| 500 ## - GENERAL NOTE | |
| General note | 5. Conclusions. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | Volume 59 in the internationally acclaimed Advances in Clinical Chemistry contains chapters submitted from leading experts from academia and clinical laboratory science. Authors are from a diverse field of clinical chemistry disciplines and diagnostics, ranging from basic biochemical exploration to cutting-edge microarray technology. Leading experts from academia and clinical laboratory science Volume emphasizes novel laboratory advances with application to clinical laboratory diagnostics and practical basic science studies. |
| 588 ## - | |
| -- | Description based on print version record. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Clinical chemistry. |
| 9 (RLIN) | 38233 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Biochemistry. |
| 9 (RLIN) | 38234 |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Biochemistry |
| General subdivision | Periodicals. |
| 9 (RLIN) | 38235 |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Clinical chemistry |
| General subdivision | Periodicals. |
| 9 (RLIN) | 38236 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | MEDICAL |
| General subdivision | Clinical Medicine. |
| Source of heading or term | bisacsh |
| 9 (RLIN) | 38237 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | SCIENCE |
| General subdivision | Chemistry |
| -- | Clinical. |
| Source of heading or term | bisacsh |
| 9 (RLIN) | 38238 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Biochemistry. |
| Source of heading or term | fast |
| -- | (OCoLC)fst00831961 |
| 9 (RLIN) | 38234 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Clinical chemistry. |
| Source of heading or term | fast |
| -- | (OCoLC)fst00864330 |
| 9 (RLIN) | 38233 |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 9 (RLIN) | 20 |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Display text | Print version: |
| Main entry heading | Makowski, Gregory |
| Title | Advances in Clinical Chemistry |
| Place, publisher, and date of publication | Burlington : Elsevier Science, c2013 |
| International Standard Book Number | 9780124052116 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Advances in Clinical Chemistry. |
| 9 (RLIN) | 2504 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="http://www.sciencedirect.com/science/book/9780124052116">http://www.sciencedirect.com/science/book/9780124052116</a> |
| 938 ## - | |
| -- | EBL - Ebook Library |
| -- | EBLB |
| -- | EBL1107826 |
| 938 ## - | |
| -- | EBSCOhost |
| -- | EBSC |
| -- | 518428 |
| 938 ## - | |
| -- | YBP Library Services |
| -- | YANK |
| -- | 9956093 |
| 938 ## - | |
| -- | Ingram Digital eBook Collection |
| -- | IDEB |
| -- | cis25645113 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | Ebook |
| 956 ## - LOCAL ELECTRONIC LOCATION AND ACCESS (OCLC) | |
| Electronic name | Consortium |
| 994 ## - | |
| -- | C0 |
| -- | TEF |
Pas d'exemplaire disponible.
